Guangzhou Boji Medical and Biotechnological Co Ltd (300404.SZ) stock: key figures, P/E, revenue and dividend

Health Care · Life Sciences Tools & Services · China · ISIN CNE100001Y00

Price
11.88 CNY
Market cap
4.58 bn CNY
P/E (2025)
150.27
P/S (2025)
5.28
Dividend yield
0.11 %
Net margin
3.51 %
Return on equity (ROE)
2.88 %
Return on assets (ROA)
1.87 %

Guangzhou Boji Medical and Biotechnological Co Ltd financials

Fiscal year20242025
Revenue742.02 m CNY868.64 m CNY
Gross profit225.39 m CNY235.62 m CNY
Operating income40.71 m CNY60.05 m CNY
EBIT21.61 m CNY31.73 m CNY
Net income28.78 m CNY30.49 m CNY
Diluted EPS – continuing operations0.08 CNY0.08 CNY

Full history since 2012, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Guangzhou Boji Medical and Biotechnological Co Ltd

Boji Medical Technology Co.,Ltd. provides professional contract research services for research and development, and production of drugs and medical devices to pharmaceutical enterprises in China and internationally. The company offers pre-clinical research, clinical research, and other consulting services. It also provides clinical drug production, pilot test scale-up, process verification batch production, and drug registration and approval services. In addition, it engages in the screening, evaluation, verification, and trading of technological achievements formed in the process of new drug research and development. The company was formerly known as Guangzhou Boji Medical & Biotechnological Co., Ltd. and changed its name to Boji Medical Technology Co.,Ltd. in September 2021. Boji Medical Technology Co.,Ltd. was founded in 1998 is headquartered in Guangzhou, China.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.